Amgen Investors
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Estimated Revenue:
$10B+
Funding Status:
IPO
Industry:
Pharma
Last Funding Date:
2022-12-12
Acquisitions Number:
Made Acquisitions
Number Of Exists:
6
Technology:
Space Medicine
Founded Date:
1980-01-01
Investor Type:
Undisclosed
Headquarters:
Thousand Oaks, California, United States
Total Funding:
28500000000.0
Last Funding Type:
Post-IPO Debt
Employee Number:
10001+
Investment Stage:
N/A